Medtide, Inc. Class H (HK:3880)

:3880

3880

Medtide, Inc. Class H

RESEARCH TOOLSreports

Compare Medtide, Inc. Class H (3880) vs. Competitors

0 Followers

Comparison Results

3880

Medtide, Inc. Class H

HK$30.00

HK$3.20B

13.56

-26.75%

―

Genor Biopharma Holdings Limited

HK$3.06

HK$6.04B

2.00

52.02%

―

Jacobio Pharmaceuticals Group Co., Ltd.

HK$7.22

HK$5.68B

-31.16

153.33%

2 Buy

0 Hold

0 Sell

Moderate Buy

Viva Biotech Holdings

HK$1.76

HK$4.12B

3.99

44.44%

―

Clover Biopharmaceuticals Ltd.

HK$2.37

HK$4.00B

-13.26

1373.68%

―

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H

HK$6.15

HK$3.87B

-8.57

-4.24%

―

xxxxxxxxxxxxx

3880 vs 1541

xxxxxxxxxxxxx

Performance Comparison

HK:3880

Medtide, Inc. Class H

22.56

-9.64

-29.94%

HK:6998

Genor Biopharma Holdings Limited

3.01

0.90

42.65%

HK:1167

Jacobio Pharmaceuticals Group Co., Ltd.

7.22

3.95

120.80%

HK:1873

Viva Biotech Holdings

1.95

0.50

34.48%

HK:2197

Clover Biopharmaceuticals Ltd.

3.08

2.88

1440.00%

HK:1541

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H

4.74

-0.66

-12.22%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >